Assessment of Effect of Rapastinel on Driving Performance

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2018
Based on the pharmacological class of rapastinel, this study will be conducted to evaluate the participant's driving performance after single IV doses of rapastinel as compared with single oral doses of alprazolam, a benzodiazepine that demonstrates driving impairment, and placebo in healthy participants.
Epistemonikos ID: 248410e90c4d54458412b71a11ee15e6d87dc4cf
First added on: May 21, 2024